Dosage of amyloid precursor protein affects axonal contact guidance in Down syndrome

Autores
Sosa, Lucas Javier; Postma, Nienke L.; Estrada-Bernal, Adriana; Hanna, M.; Guo, R.; Busciglio, Jorge; Pfenninger, Karl H.
Año de publicación
2014
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Amyloid precursor protein (APP), encoded on Hsa21, functions as a cell adhesion molecule (CAM) in axonal growth cones (GCs) of the developing brain. We show here that axonal GCs of human fetal Down syndrome (DS) neurons (and of a DS mouse model) overexpress APP protein relative to euploid controls. We investigated whether DS neurons generate an abnormal, APP-dependent GC phenotype in vitro. On laminin, which binds APP and 1 integrins (Itgb1), DS neurons formed enlarged and faster-advancing GCs compared to controls. On peptide matrices that bind APP only, but not on those binding exclusively Itgb1 or L1CAM, DS GCs were significantly enlarged (2.0-fold), formed increased close adhesions (1.8-fold), and advanced faster (1.4-fold). In assays involving alternating stripes of monospecific matrices, human control GCs exhibited no preference for any of the substrates, whereas DS GCs preferred the APP-binding matrix (cross-over decreased significantly from 48.2 to 27.2%). Reducing APP expression in DS GCs with siRNA normalized most measures of the phenotype, including substrate choice. These experiments show that human DS neurons exhibit an APP-dependent, abnormal GC phenotype characterized by increased adhesion and altered contact guidance. The results suggest that APP overexpression may perturb axonal pathfinding and circuit formation in developing DS brain.
Fil: Sosa, Lucas Javier. University Of Colorado Anschutz Medical Center, Aurora; Estados Unidos
Fil: Postma, Nienke L.. School of Medicine, Aurora; Estados Unidos
Fil: Estrada-Bernal, Adriana. School of Medicine, Aurora; Estados Unidos. University Of Colorado Anschutz Medical Center, Aurora; Estados Unidos
Fil: Hanna, M.. University of California at Irvine; Estados Unidos
Fil: Guo, R.. University of Colorado; Estados Unidos
Fil: Busciglio, Jorge. University of California at Irvine; Estados Unidos
Fil: Pfenninger, Karl H.. University Of Colorado Anschutz Medical Center, Aurora; Estados Unidos
Materia
BRAIN DEVELOPMENT
NEURODEVELOPMENTAL DISORDERS
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/130547

id CONICETDig_73f8f47aa73cf71e39784fb5aae26160
oai_identifier_str oai:ri.conicet.gov.ar:11336/130547
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Dosage of amyloid precursor protein affects axonal contact guidance in Down syndromeSosa, Lucas JavierPostma, Nienke L.Estrada-Bernal, AdrianaHanna, M.Guo, R.Busciglio, JorgePfenninger, Karl H.BRAIN DEVELOPMENTNEURODEVELOPMENTAL DISORDERShttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Amyloid precursor protein (APP), encoded on Hsa21, functions as a cell adhesion molecule (CAM) in axonal growth cones (GCs) of the developing brain. We show here that axonal GCs of human fetal Down syndrome (DS) neurons (and of a DS mouse model) overexpress APP protein relative to euploid controls. We investigated whether DS neurons generate an abnormal, APP-dependent GC phenotype in vitro. On laminin, which binds APP and 1 integrins (Itgb1), DS neurons formed enlarged and faster-advancing GCs compared to controls. On peptide matrices that bind APP only, but not on those binding exclusively Itgb1 or L1CAM, DS GCs were significantly enlarged (2.0-fold), formed increased close adhesions (1.8-fold), and advanced faster (1.4-fold). In assays involving alternating stripes of monospecific matrices, human control GCs exhibited no preference for any of the substrates, whereas DS GCs preferred the APP-binding matrix (cross-over decreased significantly from 48.2 to 27.2%). Reducing APP expression in DS GCs with siRNA normalized most measures of the phenotype, including substrate choice. These experiments show that human DS neurons exhibit an APP-dependent, abnormal GC phenotype characterized by increased adhesion and altered contact guidance. The results suggest that APP overexpression may perturb axonal pathfinding and circuit formation in developing DS brain.Fil: Sosa, Lucas Javier. University Of Colorado Anschutz Medical Center, Aurora; Estados UnidosFil: Postma, Nienke L.. School of Medicine, Aurora; Estados UnidosFil: Estrada-Bernal, Adriana. School of Medicine, Aurora; Estados Unidos. University Of Colorado Anschutz Medical Center, Aurora; Estados UnidosFil: Hanna, M.. University of California at Irvine; Estados UnidosFil: Guo, R.. University of Colorado; Estados UnidosFil: Busciglio, Jorge. University of California at Irvine; Estados UnidosFil: Pfenninger, Karl H.. University Of Colorado Anschutz Medical Center, Aurora; Estados UnidosFederation of American Societies for Experimental Biology2014-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/130547Sosa, Lucas Javier; Postma, Nienke L.; Estrada-Bernal, Adriana; Hanna, M.; Guo, R.; et al.; Dosage of amyloid precursor protein affects axonal contact guidance in Down syndrome; Federation of American Societies for Experimental Biology; FASEB Journal; 28; 1; 1-2014; 195-2050892-66381530-6860CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://faseb.onlinelibrary.wiley.com/doi/10.1096/fj.13-232686info:eu-repo/semantics/altIdentifier/doi/10.1096/fj.13-232686info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:56:44Zoai:ri.conicet.gov.ar:11336/130547instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:56:44.979CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Dosage of amyloid precursor protein affects axonal contact guidance in Down syndrome
title Dosage of amyloid precursor protein affects axonal contact guidance in Down syndrome
spellingShingle Dosage of amyloid precursor protein affects axonal contact guidance in Down syndrome
Sosa, Lucas Javier
BRAIN DEVELOPMENT
NEURODEVELOPMENTAL DISORDERS
title_short Dosage of amyloid precursor protein affects axonal contact guidance in Down syndrome
title_full Dosage of amyloid precursor protein affects axonal contact guidance in Down syndrome
title_fullStr Dosage of amyloid precursor protein affects axonal contact guidance in Down syndrome
title_full_unstemmed Dosage of amyloid precursor protein affects axonal contact guidance in Down syndrome
title_sort Dosage of amyloid precursor protein affects axonal contact guidance in Down syndrome
dc.creator.none.fl_str_mv Sosa, Lucas Javier
Postma, Nienke L.
Estrada-Bernal, Adriana
Hanna, M.
Guo, R.
Busciglio, Jorge
Pfenninger, Karl H.
author Sosa, Lucas Javier
author_facet Sosa, Lucas Javier
Postma, Nienke L.
Estrada-Bernal, Adriana
Hanna, M.
Guo, R.
Busciglio, Jorge
Pfenninger, Karl H.
author_role author
author2 Postma, Nienke L.
Estrada-Bernal, Adriana
Hanna, M.
Guo, R.
Busciglio, Jorge
Pfenninger, Karl H.
author2_role author
author
author
author
author
author
dc.subject.none.fl_str_mv BRAIN DEVELOPMENT
NEURODEVELOPMENTAL DISORDERS
topic BRAIN DEVELOPMENT
NEURODEVELOPMENTAL DISORDERS
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.1
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Amyloid precursor protein (APP), encoded on Hsa21, functions as a cell adhesion molecule (CAM) in axonal growth cones (GCs) of the developing brain. We show here that axonal GCs of human fetal Down syndrome (DS) neurons (and of a DS mouse model) overexpress APP protein relative to euploid controls. We investigated whether DS neurons generate an abnormal, APP-dependent GC phenotype in vitro. On laminin, which binds APP and 1 integrins (Itgb1), DS neurons formed enlarged and faster-advancing GCs compared to controls. On peptide matrices that bind APP only, but not on those binding exclusively Itgb1 or L1CAM, DS GCs were significantly enlarged (2.0-fold), formed increased close adhesions (1.8-fold), and advanced faster (1.4-fold). In assays involving alternating stripes of monospecific matrices, human control GCs exhibited no preference for any of the substrates, whereas DS GCs preferred the APP-binding matrix (cross-over decreased significantly from 48.2 to 27.2%). Reducing APP expression in DS GCs with siRNA normalized most measures of the phenotype, including substrate choice. These experiments show that human DS neurons exhibit an APP-dependent, abnormal GC phenotype characterized by increased adhesion and altered contact guidance. The results suggest that APP overexpression may perturb axonal pathfinding and circuit formation in developing DS brain.
Fil: Sosa, Lucas Javier. University Of Colorado Anschutz Medical Center, Aurora; Estados Unidos
Fil: Postma, Nienke L.. School of Medicine, Aurora; Estados Unidos
Fil: Estrada-Bernal, Adriana. School of Medicine, Aurora; Estados Unidos. University Of Colorado Anschutz Medical Center, Aurora; Estados Unidos
Fil: Hanna, M.. University of California at Irvine; Estados Unidos
Fil: Guo, R.. University of Colorado; Estados Unidos
Fil: Busciglio, Jorge. University of California at Irvine; Estados Unidos
Fil: Pfenninger, Karl H.. University Of Colorado Anschutz Medical Center, Aurora; Estados Unidos
description Amyloid precursor protein (APP), encoded on Hsa21, functions as a cell adhesion molecule (CAM) in axonal growth cones (GCs) of the developing brain. We show here that axonal GCs of human fetal Down syndrome (DS) neurons (and of a DS mouse model) overexpress APP protein relative to euploid controls. We investigated whether DS neurons generate an abnormal, APP-dependent GC phenotype in vitro. On laminin, which binds APP and 1 integrins (Itgb1), DS neurons formed enlarged and faster-advancing GCs compared to controls. On peptide matrices that bind APP only, but not on those binding exclusively Itgb1 or L1CAM, DS GCs were significantly enlarged (2.0-fold), formed increased close adhesions (1.8-fold), and advanced faster (1.4-fold). In assays involving alternating stripes of monospecific matrices, human control GCs exhibited no preference for any of the substrates, whereas DS GCs preferred the APP-binding matrix (cross-over decreased significantly from 48.2 to 27.2%). Reducing APP expression in DS GCs with siRNA normalized most measures of the phenotype, including substrate choice. These experiments show that human DS neurons exhibit an APP-dependent, abnormal GC phenotype characterized by increased adhesion and altered contact guidance. The results suggest that APP overexpression may perturb axonal pathfinding and circuit formation in developing DS brain.
publishDate 2014
dc.date.none.fl_str_mv 2014-01
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/130547
Sosa, Lucas Javier; Postma, Nienke L.; Estrada-Bernal, Adriana; Hanna, M.; Guo, R.; et al.; Dosage of amyloid precursor protein affects axonal contact guidance in Down syndrome; Federation of American Societies for Experimental Biology; FASEB Journal; 28; 1; 1-2014; 195-205
0892-6638
1530-6860
CONICET Digital
CONICET
url http://hdl.handle.net/11336/130547
identifier_str_mv Sosa, Lucas Javier; Postma, Nienke L.; Estrada-Bernal, Adriana; Hanna, M.; Guo, R.; et al.; Dosage of amyloid precursor protein affects axonal contact guidance in Down syndrome; Federation of American Societies for Experimental Biology; FASEB Journal; 28; 1; 1-2014; 195-205
0892-6638
1530-6860
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://faseb.onlinelibrary.wiley.com/doi/10.1096/fj.13-232686
info:eu-repo/semantics/altIdentifier/doi/10.1096/fj.13-232686
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Federation of American Societies for Experimental Biology
publisher.none.fl_str_mv Federation of American Societies for Experimental Biology
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842269421296418816
score 13.13397